Financial Statements

Emergent BioSolutions Inc. (EBS)


+1.71 (+5.38%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 727422367337-
Net Income 231305556383
Stock Dividends ----32254
Dividend Paid -----
Retained Earnings 958727422367337

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 644542510407-
Annual Depreciation 381243119175462
Capital Expenditure -225-141-87-72-55
Net PPE 800644542510407

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -49260267267
New Purchases -----
Intangible and Goodwill 49260267267225

Emergent BioSolutions Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Emergent BioSolutions Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.